Actively Recruiting

Age: 1Year - 14Years
All Genders
NCT07248930

Lipopolysaccharide Adsorption (Efferon LPS NEO) in Children With Thermal Burns

Led by Efferon JSC · Updated on 2025-11-25

30

Participants Needed

2

Research Sites

78 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This observational pilot study aims to identify criteria for evaluating the effectiveness of hemoadsorption with the Efferon LPS NEO device in pediatric burn injury. Participants will be prospectively assigned to the treatment group and compared with a retrospectively selected control group. Each patient in the treatment group will undergo two hemoadsorption sessions, each lasting 6-12 hours, with an interval of 24-120 hours between procedures. The sessions may be performed in combination with hemofiltration or hemodiafiltration at the discretion of the investigator.

CONDITIONS

Official Title

Lipopolysaccharide Adsorption (Efferon LPS NEO) in Children With Thermal Burns

Who Can Participate

Age: 1Year - 14Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Thermal burns of degree I and II with a lesion area of 40% or more (ICD-10: T20-T25, T29)
  • Frank index greater than 90, indicating severe burn depth and area
  • Hemoadsorption treatment started no later than 5 days after ICU admission
  • Adequate infusion therapy of at least 30 mL/kg from study inclusion until first sorption
  • Patient's condition allows for at least 6 hours of Efferon LPS NEO therapy
Not Eligible

You will not qualify if you...

  • Presence of end-stage renal disease
  • Acute pulmonary embolism confirmed by CT scan
  • Uncontrolled bleeding with acute blood loss within the last 24 hours

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Children's City Clinical Hospital No. 9 named after G.N. Speransky of the Moscow City Health Department

Moscow, Russia, 123317

Actively Recruiting

2

Children's municipal multi-specialty clinical center of high medical technology

Saint Petersburg, Russia

Actively Recruiting

Loading map...

Research Team

A

Alexandr Shelehov-Kravchenko, PhD, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here